跳至主要内容
临床试验/CTRI/2018/05/014158
CTRI/2018/05/014158招募中未知

Prospective study to identify biomarkers of chemoresistance to neoadjuvant chemotherapy and discover targetable pathways in triple-negative breast cancer

Tata Memorial Centre0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Tissue blocks from women with non-metastatic, triple negative breast cancer, who are eligible for neoadjuvant chemotherapy and have received NACT under the ongoing randomized trial at TMC (CTRI/2012/07/002802), will be included in the study.
  • TNBC with available paired paraffin samples (pre-NACT and post-surgery) will be included.

排除标准

  • Metastatic Breast Cancer patient

研究者

相似试验